• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The First Drug With A $1 Million Price Tag May Already Be On The Market

Article

In March, comparing the price of a cancer drug on a per capita basis here and in India, I told drug companies how to charge $1.6 million per patient for a new drug — and get away with it. So long as companies make sure that all patients have access, I argued, it’s possible to convince governments and insurers to pay truly princely sums for medicines that really help patients.

Still, I thought that $1.6 million, was a sky high, off-the-charts, unbelievable amount. Surely, no medicine for sale today cost more than $1 million I thought. In fact, the priciest one I can name is Soliris, from biotech high-flyer Alexion, which costs $500,000 per patient — a lot, but still only half a million. Turns out I was wrong — it’s possible that medicines that are already on the market could rise to this price point, if they continue to help young patients grow bigger.

Read the full story: http://hcp.lv/Jnp488

Source: Forbes

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Stephanie L. Graff, MD, an expert on breast cancer
Debra Boyer, MD, MHPE, ATSF.
Ioana Preston, MD, a pulmonologist
B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS
A panel of 5 experts on Alzheimer disease
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Mila Felder, MD, FACEP, emergency physician and vice president for Well-Being for All Teammates, Advocate Health
Plasminogen is vital in the body's coagulation process and breaking down clots | image credit: peterschreiber.media - stock.adobe.com
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.